Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease
17 févr. 2021 01h15 HE
|
Novartis International AG
Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation Agreement aims to address disparity in access to treatments and to prioritize...
Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
11 févr. 2021 07h00 HE
|
Novartis International AG
Sandoz to acquire three established brands sold in more than 100 marketsAcquisition, including leading global brand Zinnat®, confirms Sandoz commitment to antibiotics, following plans to expand its...
ModivCare Delivers Free, Fresh Produce to Trenton Residents in Need
04 févr. 2021 09h00 HE
|
LogistiCare
Trenton, NJ, Feb. 04, 2021 (GLOBE NEWSWIRE) -- ModivCare Solutions, LLC (“ModivCare”), formerly LogistiCare Solutions, LLC, the nation’s largest non-emergency medical transportation company and the...
En 2020, Novartis a enregistré une croissance de son chiffre d’affaires et de sa marge; il a continué de faire progresser sa prochaine vague de médicaments
26 janv. 2021 01h00 HE
|
Novartis International AG
Chiffre d’affaires net des activités poursuivies1 en hausse de 3% (tcc2, +3% USD): Pharmaceuticals: cette unité opérationnelle a progressé de 5% (tcc), soutenue par Entresto...
Novartis hat 2020 Umsatz und Margen gesteigert und die nächste Welle von Medikamenten weiter vorangetrieben
26 janv. 2021 01h00 HE
|
Novartis International AG
Der Nettoumsatz der fortzuführenden Geschäftsbereiche¹ stieg im Geschäftsjahr um 3% (kWk², +3% USD): Die Geschäftseinheit Pharmaceuticals wuchs um 5% (kWk), wozu vor allem Entresto (+44% kWk),...
Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020.
26 janv. 2021 01h00 HE
|
Novartis International AG
Full year net sales from continuing operations¹ up 3% (cc², +3% USD): Pharmaceuticals BU grew 5% (cc) driven by Entresto (+44% cc), Zolgensma (reaching USD 0.9 billion), Cosentyx (+13%...
LogistiCare Partners with Care Finders Total Care, LLC and Lyft to Create Unique Program Providing Critical Transportation Support for Home Health Aides
09 déc. 2020 09h00 HE
|
LogistiCare
Denver, CO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- LogistiCare, the nation’s largest non-emergency medical transportation company and the contracted transportation vendor for New Jersey Medicaid...
Novartis au T3: performance solide, croissance de 11% du résultat opérationnel core, chiffre d’affaires net proche de l’an dernier, pipeline en fort progrès; hausse du résultat opérationnel core prévu
27 oct. 2020 02h00 HE
|
Novartis International AG
Chiffre d’affaires net des activités poursuivies1 au T3 en ligne avec celui de l’exercice précédent (tcc2, +1% USD): Les moteurs de la croissance ont été notamment Entresto USD 632 millions (+45%...
Novartis im 3. Qu. mit solider Performance: operatives Kernergebnis steigt um 11%, Nettoumsatz auf Vorjahresniveau, starke Pipeline-Fortschritte; Jahresprognose für operatives Kernergebnis angehoben
27 oct. 2020 02h00 HE
|
Novartis International AG
Im dritten Quartal 2020 lag der Nettoumsatz der fortzuführenden Geschäftsbereiche1 auf dem Niveau des Vorjahres (kWk2, +1% USD): Zu den Wachstumsträgern gehörten Entresto (USD 632 Millionen,...
Novartis delivers solid Q3 performance with 11% core operating income growth, net sales in line with prior year, strong pipeline progression. Upgrades full year core operating income guidance.
27 oct. 2020 02h00 HE
|
Novartis International AG
Q3 net sales from continuing operations1 were in line with prior year (cc2, +1% USD): Growth drivers included Entresto USD 632 million (+45% cc), Zolgensma USD 291 million (+79% cc), Cosentyx USD 1...